References
- Barik, A., Rai, G., Modi, G. (2020). Molecular docking and binding mode analysis of selected FDA approved drugs against COVID-19 selected key protein targets: An effort towards drug repurposing to identify the combination therapy to combat COVID-19. http://arxiv.org/abs/2004.06447
- Beck, B. R., Shin, B., Choi, Y., Park, S., & Kang, K. (2020). Predicting commercially available antiviral drugs that may act on the novel coronavirus (SARS-CoV-2) through a drug-target interaction deep learning model. Computational and Structural Biotechnology Journal, 18, 784–790. https://doi.org/https://doi.org/10.1016/j.csbj.2020.03.025
- Bowers, E., Chow, H., Xu, R. O., Dror, M. P., Eastwood, B. A., Gregersen, J. L., Klepeis, I., Kolossváry, M. A., Moraes, F. D., Sacerdoti, J. K., Salmon, Y., & Shan, D. E. S. ( 2006). Scalable algorithms for molecular dynamics simulations on commodity clusters [Paper presentation]. ACM/IEEE Conference on Supercomputing, Tampa, FL, USA. https://doi.org/https://doi.org/10.1109/SC.2006.54
- Chen, T. Y., Chen, D. Y., Wen, H. W., Ou, J. L., Chiou, S. S., Chen, J. M., Wong, M. L., & Hsu, W. L. (2013). Inhibition of enveloped viruses infectivity by curcumin. PLoS One, 8(5), e62482. https://doi.org/https://doi.org/10.1371/journal.pone.0062482
- Chen, A. L., Hsu, C. H., Lin, J. K., Hsu, M. M., Ho, Y. F., She, T. S., Ko, J. Y., Lin, J. T., Lin, B. R., Wu, M. S., Yu, H. S., Jee, S. H., Chen, G. S., Chen, T. M., Chen, C. A., Lai, M. K., Pu, Y. S., Pan, M. H., Wang, Y. J., … Hsieh, C. Y. (2001). Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Research, 21, 2895–2900.
- Chen, M. H., Lee, M. Y., Chuang, J. J., Li, Y. Z., Ning, S. T., Chen, J. C., & Liu, Y. W. (2012). Curcumin inhibits HCV replication by induction of heme oxygenase-1 and suppression of AKT. International Journal of Molecular Medicine, 30(5), 1021–1028. https://doi.org/https://doi.org/10.3892/ijmm.2012.1096
- Chen, D. Y., Shien, J. H., Tiley, L., Chiou, S. S., Wang, S. Y., Chang, T. J., Lee, Y. J., Chan, K. W., & Hsu, W. L. (2010). Curcumin inhibits influenza virus infection and haemagglutination activity. Food Chemistry, 119(4), 1346–1351. https://doi.org/https://doi.org/10.1016/j.foodchem.2009.09.011
- Chen, J. J., Tsai, C. S., Hwang, T. L., Shieh, P. C., Chen, J. F., & Sung, P. J. (2010). Sesquiterpenes from the rhizome of Curcuma longa with inhibitory activity on superoxide generation and elastase release by neutrophils. Food Chemistry, 119(3), 974–980. https://doi.org/https://doi.org/10.1016/j.foodchem.2009.07.060
- ÇIkrıkçI, S., Mozi̇Og˘Lu, E., &., & Yılmaz, H., (2008). Biological activity of curcuminoids isolated from Curcuma longa. Records of Natural Products, 2(1), 19-24.
- Dhillon, N., Aggarwal, B. B., Newman, R. A., Wolff, R. A., Kunnumakkara, A. B., Abbruzzese, J. L., Ng, C. S., Badmaev, V., & Kurzrock, R. (2008). Phase II trial of curcumin in patients with advanced pancreatic cancer. Clinical Cancer Research, 14(14), 4491–4499. https://doi.org/https://doi.org/10.1158/1078-0432.CCR-08-0024
- Ekins, S., Mottin, M., Ramos, P. R. P. S. P. S. P. S., Sousa, B. K. P. P. P., Neves, B. J., Foil, D. H., Zorn, K. M., Braga, R. C., Coffee, M., Southan, C., Puhl, A. C., & Andrade, C. H. (2020). Déjà vu: Stimulating open drug discovery for SARS-CoV-2. Drug Discovery Today, 25(5), 928–912. https://doi.org/https://doi.org/10.1016/j.drudis.2020.03.019
- Elfiky, A. A. (2020a). Anti-HCV, nucleotide inhibitors, repurposing against COVID-19. Life Sciences, 248, 117477(January). https://doi.org/https://doi.org/10.1016/j.lfs.2020.117477
- Elfiky, A. A. (2020b). Ribavirin, remdesivir, sofosbuvir, galidesivir, and tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study. Life Sciences, 253, 117592. https://doi.org/https://doi.org/10.1016/j.lfs.2020.117592
- Frisch, G. W., Trucks, H. B., Schlegel, G. E., Scuseria, M. A., Robb, J. R., Cheeseman, G., Scalmani, V., Barone, B., Mennucci, G. A., Petersson, H., Nakatsuji, M., Caricato, X., Li, H. P., Hratchian, A. F., Izmaylov, J., Bloino, G., Zheng, J. L., Sonnenberg, M., & Had, D. J. F. (2009). Gaussian 09, Revision E.01,. In Gaussian, Inc. (No. 09).
- Gao, Y., Yan, L., Huang, Y., Liu, F., Zhao, Y., Cao, L., Wang, T., Sun, Q., Ming, Z., Zhang, L., Ge, J., Zheng, L., Zhang, Y., Wang, H., Zhu, Y., Zhu, C., Hu, T., Hua, T., Zhang, B., … Rao, Z. (2020). Structure of the RNA-dependent RNA polymerase from COVID-19 virus. Science ( Science.), 368(6492), 779–779. https://doi.org/https://doi.org/10.1126/science.abb7498
- Gupta, A. P., Gupta, M. M., & Kumar, S. (1999). Simultaneous determination of curcuminoids in Curcuma samples using high performance thin layer chromatography. Journal of Liquid Chromatography and Related Technologies, 22(10), 1561-1569. https://doi.org/https://doi.org/10.1081/JLC-100101751
- Gupta, S. C., Patchva, S., Aggarwal, B. B. (2013). Therapeutic roles of curcumin: Lessons learned from clinical trials. The AAPS Journal, 15(1), 195–218. https://doi.org/https://doi.org/10.1208/s12248-012-9432-8
- Harder, E., Damm, W., Maple, J., Wu, C., Reboul, M., Xiang, J. Y., Wang, L., Lupyan, D., Dahlgren, M. K., Knight, J. L., Kaus, J. W., Cerutti, D. S., Krilov, G., Jorgensen, W. L., Abel, R., & Friesner, R. A. (2016). OPLS3: A force field providing broad coverage of drug-like small molecules and Proteins. Journal of Chemical Theory and Computation, 12(1), 281–296. https://doi.org/https://doi.org/10.1021/acs.jctc.5b00864
- Hewlings, S., & Kalman, D. (2017). Curcumin: A review of its’ effects on human health. Foods, 6(10), 92. https://doi.org/https://doi.org/10.3390/foods6100092
- Ibrahim, I. M., Abdelmalek, D. H., Elshahat, M. E., & Elfiky, A. A. (2020). COVID-19 spike-host cell receptor GRP78 binding site prediction. The Journal of Infection, 80(5), 554–562. https://doi.org/https://doi.org/10.1016/j.jinf.2020.02.026
- Jacobson, M. P., Pincus, D. L., Rapp, C. S., Day, T. J. F., Honig, B., Shaw, D. E., & Friesner, R. A. (2004). A hierarchical approach to all-atom protein loop prediction. Proteins: Structure, Function, and Bioinformatics, 55(2), 351–367. https://doi.org/https://doi.org/10.1002/prot.10613
- Jin, Z., Du, X., Xu, Y., Deng, Y., Liu, M., Zhao, Y., Zhang, B., Li, X., Zhang, L., Peng, C., Duan, Y., Yu, J., Wang, L., Yang, K., Liu, F., Jiang, R., Yang, X., You, T., Liu, X., … Yang, H. (2020). Structure of Mpro from COVID-19 virus and discovery of its inhibitors. Nature, 582(7811), 289–293. 2020.02.26.964882. https://doi.org/https://doi.org/10.1038/s41586-020-2223-y
- Kalirajan, R., Pandiselvi, A., Gowramma, B., & Balachandran, P. (2019). In-silico design, ADMET Screening, MM-GBSA binding free energy of some novel isoxazole substituted 9-Anilinoacridines as HER2 inhibitors targeting breast cancer. Current Drug Research Reviews, 11(2), 118–128. https://doi.org/https://doi.org/10.2174/2589977511666190912154817
- Kandeel, M., & Al-Nazawi, M. (2020). Virtual screening and repurposing of FDA approved drugs against COVID-19 main protease. Life Sciences, 251(April), 117627 https://doi.org/https://doi.org/10.1016/j.lfs.2020.117627
- Lal, B., Kapoor, A. K., Asthana, O. P., Agrawal, P. K., Prasad, R., Kumar, P., & Srimal, R. C. (1999). Efficacy of curcumin in the management of chronic anterior uveitis. Phytotherapy Research, 13(4), 318–322. https://doi.org/https://doi.org/10.1002/(SICI)1099-1573(199906)13:4<318::AID-PTR445>3.0.CO;2-7
- Li, S. (2011). Chemical composition and product quality control of turmeric (Curcuma longa L.). Pharmaceutical Crops, 5(1), 28–54. https://doi.org/https://doi.org/10.2174/2210290601102010028
- Liu, C., Zhou, Q., Li, Y., Garner, L. V., Watkins, S. P., Carter, L. J., Smoot, J., Gregg, A. C., Daniels, A. D., Jervey, S., & Albaiu, D. (2020). Research and development on therapeutic agents and vaccines for COVID-19 and related human coronavirus diseases. ACS Central Science, 6(3), 315–331. https://doi.org/https://doi.org/10.1021/acscentsci.0c00272
- Li, H., Zhong, C., Wang, Q., Chen, W., & Yuan, Y. (2019). Curcumin is an APE1 redox inhibitor and exhibits an antiviral activity against KSHV replication and pathogenesis. Antiviral Research, 167, 98–103. https://doi.org/https://doi.org/10.1016/j.antiviral.2019.04.011
- Lu, R., Zhao, X., Li, J., Niu, P., Yang, B., Wu, H., Wang, W., Song, H., Huang, B., Zhu, N., Bi, Y., Ma, X., Zhan, F., Wang, L., Hu, T., Zhou, H., Hu, Z., Zhou, W., Zhao, L., … Tan, W. (2020). Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding. The Lancet, 395(10224), 565–574. https://doi.org/https://doi.org/10.1016/S0140-6736(20)30251-8
- Lung, J., Lin, Y. S., Yang, Y. H., Chou, Y. L., Shu, L. H., Cheng, Y. C., Liu, H., Te., & Wu, C. Y. (2020). The potential chemical structure of anti-SARS-CoV-2 RNA-dependent RNA polymerase. Journal of Medical Virology, 92(6), 693–695. (March),https://doi.org/https://doi.org/10.1002/jmv.25761
- Mathew, D., & Hsu, W. L. (2018). Antiviral potential of curcumin. Journal of Functional Foods, 40, 692–699. In https://doi.org/https://doi.org/10.1016/j.jff.2017.12.017
- Menteşe, E., Akyüz, G., Emirik, M., & Baltaş, N. (2019). Synthesis, in vitro urease inhibition and molecular docking studies of some novel quinazolin-4(3H)-one derivatives containing triazole, thiadiazole and thiosemicarbazide functionalities. Bioorganic Chemistry, 83, 289–296. https://doi.org/https://doi.org/10.1016/j.bioorg.2018.10.031
- Mermer, A., Bayrak, H., Şirin, Y., Emirik, M., & Demirbaş, N. (2019). Synthesis of novel Azol-$β$-lactam derivatives starting from phenyl piperazine and investigation of their antiurease activity and antioxidant capacity comparing with their molecular docking studies. Journal of Molecular Structure, 1189, 279–287. https://doi.org/https://doi.org/10.1016/j.molstruc.2019.04.039
- Mounce, B. C., Cesaro, T., Carrau, L., Vallet, T., & Vignuzzi, M. (2017). Curcumin inhibits Zika and chikungunya virus infection by inhibiting cell binding. Antiviral Research, 142, 148–157. https://doi.org/https://doi.org/10.1016/j.antiviral.2017.03.014
- Muralidharan, N., Sakthivel, R., Velmurugan, D., & Gromiha, M. M. (2020). Computational studies of drug repurposing and synergism of lopinavir, oseltamivir and ritonavir binding with SARS-CoV-2 Protease against COVID-19. Journal of Biomolecular Structure & Dynamics, 0(0), 1–7. https://doi.org/https://doi.org/10.1080/07391102.2020.1752802
- Narayanan, A., Kehn-Hall, K., Senina, S., Lundberg, L., Van Duyne, R., Guendel, I., Das, R., Baer, A., Bethel, L., Turell, M., Hartman, A. L., Das, B., Bailey, C., & Kashanchi, F. (2012). Curcumin inhibits rift valley fever virus replication in human cells. The Journal of Biological Chemistry, 287(40), 33198–33214. https://doi.org/https://doi.org/10.1074/jbc.M112.356535
- Ntie-Kang, F. (2013). An in silico evaluation of the ADMET profile of the StreptomeDB database. SpringerPlus, 2(1), 353–311. https://doi.org/https://doi.org/10.1186/2193-1801-2-353
- Özil, M., Tacal, G., Baltaş, N., & Emirik, M. (2020). Synthesis and molecular docking studies of novel triazole derivatives as antioxidant agents. Letters in Organic Chemistry, 17(4), 309–320. https://doi.org/https://doi.org/10.2174/1570178616666190828200207
- Pant, R., Joshi, A., Maiti, P., Nand, M., Pande, V., & Chandra, S. (2020). Identification of potential mycolyltransferase Ag85C inhibitors of Mycobacterium tuberculosis H37Rv via virtual high throughput screening and binding free energy studies. Journal of Molecular Graphics & Modelling, 98, 107584 https://doi.org/https://doi.org/10.1016/j.jmgm.2020.107584
- Park, S. Y., & Kim, D. S. H. L. (2002). Discovery of natural products from Curcuma longa that protect cells from beta-amyloid insult: A drug discovery effort against Alzheimer’s disease. Journal of Natural Products, 65(9), 1227–1231. https://doi.org/https://doi.org/10.1021/np010039x
- Park, B. S., Kim, J. H. J. G., Kim, M. R., Lee, S. E., Takeoka, G. R., Oh, K. B., & Kim, J. H. J. G. (2005). Curcuma longa L. constituents inhibit sortase A and Staphylococcus aureus cell adhesion to fibronectin. Journal of Agricultural and Food Chemistry, 53(23), 9005–9009. https://doi.org/https://doi.org/10.1021/jf051765z
- Pillaiyar, T., Meenakshisundaram, S., & Manickam, M. (2020). Recent discovery and development of inhibitors targeting coronaviruses. Drug Discovery Today, 25(4), 668–688. https://doi.org/https://doi.org/10.1016/j.drudis.2020.01.015
- Prasad, S., & Tyagi, A. K. (2015). Curcumin and its analogues: A potential natural compound against HIV infection and AIDS. Food and Function, 6, 3412–3419. https://doi.org/https://doi.org/10.1039/c5fo00485c
- Rismanbaf, A. (2020). Potential Treatments for COVID-19; a Narrative Literature Review. Archives of Academic Emergency Medicine, 8(1), e29. http://www.ncbi.nlm.nih.gov/pubmed/32232214
- Roth, G. N., Chandra, A., & Nair, M. G. (1998). Novel bioactivities of Curcuma longa constituents. Journal of Natural Products, 61(4), 542–545. https://doi.org/https://doi.org/10.1021/np970459f
- Sakui, N., Kuroyanagi, M., Ishitobi, Y., Sato, M., & Ueno, A. (1992). Biotransformation of sesquiterpenes by cultured cells of Curcuma zedoaria. Phytochemistry, 31(1), 143–147. https://doi.org/https://doi.org/10.1016/0031-9422(91)83023-E
- Samant, L. R., & Javle, V. R. K. (2020). Comparative Docking analysis of rational drugs against COVID- 19 Main Protease. ChemRxiv, x(1), xx.
- Satoskar, R. R., Shah, S. J., & Shenoy, S. G. (1986). Evaluation of anti-inflammatory property of curcumin (diferuloyl methane) in patients with postoperative inflammation. International Journal of Clinical Pharmacology Therapy and Toxicology, 24(12), 651.
- Schlagenhauf, P., Grobusch, M. P., Maier, J. D., & Gautret, P. (2020). Repurposing antimalarials and other drugs for COVID-19. Travel Medicine and Infectious Disease, 34, 101658. https://doi.org/https://doi.org/10.1016/j.tmaid.2020.101658
- Schrödinger Release 2018-1 (2018a). Induced Fit Docking protocol; Glide., Schrödinger, LLC. 2016; Prime, Schrödinger, LLC.
- Schrödinger Release 2018-1 (2018b). QikProp., Schrödinger, LLC.
- Schrödinger Release 2018-4 (2018a). Maestro, Schrödinger, LLC.
- Schrödinger Release 2018-4 (2018b). Protein Preparation Wizard; Epik., Schrödinger, LLC. 2016; Impact, Schrödinger, LLC, New York, NY, 2016; Prime, Schrödinger, LLC, New York, NY, (n.d.).
- Shah, B., Modi, P., & Sagar, S. R. (2020). In silico studies on therapeutic agents for COVID-19: Drug repurposing approach. Life Sciences, 252, 117652 https://doi.org/https://doi.org/10.1016/j.lfs.2020.117652
- Shan, Y., Klepeis, J. L., Eastwood, M. P., Dror, R. O., & Shaw, D. E. (2005). Gaussian split Ewald: A fast Ewald mesh method for molecular simulation. Journal of Chemical Physics, 122(5), 0–13. https://doi.org/https://doi.org/10.1063/1.1839571
- Sharma, R. A., Euden, S. A., Platton, S. L., Cooke, D. N., Shafayat, A., Hewitt, H. R., Marczylo, T. H., Morgan, B., Hemingway, D., Plummer, S. M., Pirmohamed, M., Gescher, A. J., & Steward, W. P. (2004a). Phase I clinical trial of oral curcumin: Biomarkers of systemic activity and compliance. Clinical Cancer Research, 10(20), 6847–6854. https://doi.org/https://doi.org/10.1158/1078-0432.CCR-04-0744
- Sharma, R. A., Euden, S. A., Platton, S. L., Cooke, D. N., Shafayat, A., Hewitt, H. R., Marczylo, T. H., Morgan, B., Hemingway, D., Plummer, S. M., Pirmohamed, M., Gescher, A. J., & Steward, W. P. (2004b). Phase I clinical trial of oral curcumin. Clinical Cancer Research, 10(20), 6847–6854. https://doi.org/https://doi.org/10.1158/1078-0432.CCR-04-0744
- Sherman, W., Day, T., Jacobson, M. P., Friesner, R. A., & Farid, R. (2006). Novel procedure for modeling ligand/receptor induced fit effects. Journal of Medicinal Chemistry, 49(2), 534–553. https://doi.org/https://doi.org/10.1021/jm050540c
- Si, X., Wang, Y., Wong, J., Zhang, J., McManus, B. M., & Luo, H. (2007). Dysregulation of the ubiquitin-proteasome system by curcumin suppresses coxsackievirus B3 replication. Journal of Virology, 81(7), 3142–3150. https://doi.org/https://doi.org/10.1128/JVI.02028-06
- Takano, Y., & Houk, K. N. (2005). Benchmarking the conductor-like polarizable continuum model (CPCM) for aqueous solvation free energies of neutral and ionic organic molecules. Journal of Chemical Theory and Computation, 1(1), 70–77. https://doi.org/https://doi.org/10.1021/ct049977a
- Thiel, V., Ivanov, K. A., Putics, Á., Hertzig, T., Schelle, B., Bayer, S., Weißbrich, B., Snijder, E. J., Rabenau, H., Doerr, H. W., Gorbalenya, A. E., & Ziebuhr, J. (2003). Mechanisms and enzymes involved in SARS coronavirus genome expression. The Journal of General Virology, 84(Pt 9), 2305–2315. https://doi.org/https://doi.org/10.1099/vir.0.19424-0
- Ton, A. T., Gentile, F., Hsing, M., Ban, F., & Cherkasov, A. (2020). Rapid identification of potential inhibitors of SARS-CoV-2 main protease by deep docking of 1.3 billion compounds. Molecular Informatics, 39(8), 2000028–2000028. https://doi.org/https://doi.org/10.1002/minf.202000028
- University of Liverpool. (n.d.). Detailed recommendations for interactions with experimental COVID-19 therapies. The Liverpool Drug Interaction Group. https://www.covid19-druginteractions.org/
- Wang, J. (2020). Fast identification of possible drug treatment of Coronavirus Disease -19 (COVID-19) through computational drug repurposing study. Journal of Chemical Information and Modeling, 60(6), 3277–3286. https://doi.org/https://doi.org/10.1021/acs.jcim.0c00179
- Wang, L. Y., Zhang, M., Zhang, C. F., & Wang, Z. T. (2008). Diaryl derivatives from the root tuber of Curcuma longa. Biochemical Systematics and Ecology, 36(5-6), 476–480. https://doi.org/https://doi.org/10.1016/j.bse.2007.12.005
- WHO Director-General’s opening remarks at the media briefing on COVID-19 - 11 (2020). March 2020. (n.d.). Retrieved March 11, from https://www.who.int/dg/speeches/detail
- Wrapp, D., Wang, N., Corbett, K. S., Goldsmith, J. A., Hsieh, C. L., Abiona, O., Graham, B. S., & McLellan, J. S. (2020). Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science ( Science.), 367(6483), 1260–1263. https://doi.org/https://doi.org/10.1126/science.abb2507
- Xia, S., Liu, M., Wang, C., Xu, W., Lan, Q., Feng, S., Qi, F., Bao, L., Du, L., Liu, S., Qin, C., Sun, F., Shi, Z., Zhu, Y., Jiang, S., & Lu, L. (2020). Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion . Cell Research, 30(4), 343–355. https://doi.org/https://doi.org/10.1038/s41422-020-0305-x
- Yang, H., Yang, M., Ding, Y., Liu, Y., Lou, Z., Zhou, Z., Sun, L., Mo, L., Ye, S., Pang, H., Gao, G. F., Anand, K., Bartlam, M., Hilgenfeld, R., & Rao, Z. (2003). The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor. Proceedings of the National Academy of Sciences of the United States of America, 100(23), 13190–13195. https://doi.org/https://doi.org/10.1073/pnas.1835675100
- Yuan, M., Wu, N. C., Zhu, X., Lee, C.-C D., So, R. T. Y., Lv, H., Mok, C. K. P., & Wilson, I. A. (2020). A highly conserved cryptic epitope in the receptor-binding domains of SARS-CoV-2 and SARS-CoV. Science, 368(6491), eabb7269. (April), https://doi.org/https://doi.org/10.1126/science.abb7269
- Ziebuhr, J., Bayer, S., Cowley, J. A., & Gorbalenya, A. E. (2003). The 3C-Like proteinase of an invertebrate nidovirus links coronavirus and potyvirus homologs. Journal of Virology, 77(2), 1415–1426. https://doi.org/https://doi.org/10.1128/jvi.77.2.1415-1426.2003
- Zorofchian Moghadamtousi, S., Abdul Kadir, H., Hassandarvish, P., Tajik, H., Abubakar, S., & Zandi, K. (2014). A review on antibacterial, antiviral, and antifungal activity of curcumin. BioMed Research International, 2014, 186864 In https://doi.org/https://doi.org/10.1155/2014/186864